Cooper Companies (COO) has put mixed numbers on the table for Q2 2026, with revenue at US$1.1 billion, a reported loss of US$77.9 million and basic EPS of US$0.40 loss, setting a very different tone from the prior few quarters of positive earnings. Over the past six quarters, revenue has moved from US$964.7 million in Q1 2025 to US$1.1 billion in Q2 2026. Basic EPS has ranged from US$0.52 in Q1 2025 to US$0.67 in Q1 2026 before flipping to a loss this quarter, leaving investors focused squarely on the pressure this puts on margins and how durable any recovery in profitability might be.

See our full analysis for Cooper Companies.

With the latest results laid out, the next step is to weigh these margin trends against the most common narratives around Cooper Companies to see which stories still hold up and which need a rethink.

Margins Under Pressure Despite US$4.2b Trailing Revenue

• Over the last twelve months, Cooper Companies generated about US$4.2b in revenue and US$235.8 million in net income. This works out to a 5.6% net margin compared with 10.4% a year earlier.
• Critics highlight that this lower trailing margin sits awkwardly beside the bearish view that profit margins could reach 17.1% in a few years, and the numbers underline that gap:
  • Trailing basic EPS on a last twelve month basis is US$1.20, while quarterly EPS flipped from a profit of US$0.67 in Q1 2026 to a loss of US$0.40 in Q2 2026. This challenges the idea of a smooth path to higher profitability.
  • Bears also point to the past five year earnings decline of 49.2% per year as evidence that lifting margins from 5.6% to the mid teens would require a much cleaner profit trend than the recent results show.

On a quarter where margins compressed and EPS swung to a loss, skeptics argue their case is gaining ground. However, the full bearish narrative goes much deeper into how product mix and capital spending could shape those margins over time, which you can unpack further in the 🐻 Cooper Companies Bear Case.

Premium Valuation Meets DCF Upside

• Cooper Companies trades on a trailing P/E of 55.7x, more than double the US Medical Equipment industry at 25.3x and above the peer average of 22.3x. Yet the stock price of US$67.34 still sits roughly 47.4% below a DCF fair value of about US$128.11.
• What is striking for the bearish narrative is that it leans on a lower future P/E multiple of 18.7x while the current multiple is already high, and the data offer a mixed scorecard:
  • The valuation gap to DCF fair value suggests the current market price does not fully match that model, even though the trailing P/E of 55.7x implies investors are still paying a premium versus industry and peers.
  • At the same time, earnings over the past five years declined 49.2% per year and were negative over the last year, which critics argue makes the current premium multiple harder to reconcile with the weaker profit history.

Revenue Growth Steady, Earnings Forecasts Ambitious

• Trailing revenue growth is 4.8% per year, below the US market forecast of 11.2% per year, while earnings are forecast in the supplied data to grow about 26% annually over the next three years despite the recent Q2 2026 loss of US$77.9 million.
• Supporters of the bullish view see this tension as their key opportunity, and the figures show why it attracts attention:
  • Consensus narrative materials reference new contact lens launches and cost efficiencies. These sit alongside a trailing twelve month basic EPS of US$1.20, which bulls argue could rise significantly if those growth products and cost actions feed through to profitability.
  • The same data set that shows a 5.6% net margin today also includes forecasts of about 26% annual earnings growth, and bulls see that contrast between modest revenue growth and stronger projected EPS as a sign of potential operating leverage if execution lines up with expectations.

If you want to see how those product rollouts and cost moves might translate into the growth figures implied here, it is worth reading the fuller bullish narrative alongside these earnings numbers 🐂 Cooper Companies Bull Case

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Cooper Companies on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

Mixed signals or a clear message? The recent results and narratives point in different directions. It makes sense to review the numbers yourself, weigh the pressure points and bright spots, and then see how those stack up against the 2 key rewards and 1 important warning sign in 2 key rewards and 1 important warning sign.

See What Else Is Out There

Cooper Companies is wrestling with shrinking margins, a recent quarterly loss, a high 55.7x P/E and earnings that declined 49.2% per year over five years.

If that mix of weak earnings trends and a premium valuation gives you pause, it may be useful to compare it with 49 high quality undervalued stocks that pair stronger fundamentals with more grounded pricing at the moment.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.